Screener
Tarsus Pharmaceuticals, Inc. TARS Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $206.6M+108% | $104.19M-41.6% | $186.2M+91.2% | $115.29M-34.6% | $99.21M-45.2% | ||
| $245.1M-13.8% | $286.54M+23.4% | $233.63M+18.9% | $289.11M+105% | $284.5M+99.7% | ||
| $96.03M+64.6% | $100.34M+60.7% | $85.06M+81.9% | $72.62M+149% | $58.33M+97.5% | ||
| $2.53M-0.3% | $2.53M-0.2% | $2.53M0.0% | $2.53M0.0% | $2.53M0.0% | ||
| $561.99M+18.5% | $537.23M+11.7% | $522.78M+46.6% | $501.7M+40.5% | $474.43M+30.8% | ||
| $20.49M+544% | $17.67M+534% | $11.67M+404% | $5.75M+140% | $3.18M+42.0% | ||
| $6.89M-12.2% | $7.13M-11.9% | $7.37M-11.5% | $7.61M-11.2% | $7.85M+114% | ||
| $611.14M+23.5% | $581.14M+16.1% | $562.16M+49.1% | $534.56M+42.1% | $494.99M+31.4% | ||
| $40.14M+43.0% | $24.13M-15.0% | $16.39M+74.0% | $40.64M+51.6% | $28.08M+5.3% | ||
| $175.75M+94.7% | $143.51M+66.3% | $135.7M+68.3% | $117.05M+77.7% | $90.25M+75.0% | ||
| $72.76M+0.9% | $72.6M+0.9% | $72.44M+0.8% | $72.28M+0.8% | $72.13M+0.8% | ||
| $264.41M+62.8% | $232.18M+46.7% | $218.73M+43.5% | $199.48M+43.7% | $162.38M+30.3% | ||
| 200M0.0% | 200M0.0% | 200M0.0% | 200M0.0% | 200M0.0% | ||
| -$452.15M-11.5% | -$433.6M-12.5% | -$426.63M-18.4% | -$418.26M-24.1% | -$405.67M-29.3% | ||
| $346.73M+4.2% | $348.95M+1.9% | $343.43M+53.0% | $335.08M+41.1% | $332.61M+31.9% | ||
| $611.14M+23.5% | $581.14M+16.1% | $562.16M+49.1% | $534.56M+42.1% | $494.99M+31.4% |
FAQ
- What are Tarsus Pharmaceuticals, Inc.'s total assets?
- Tarsus Pharmaceuticals, Inc. (TARS) holds $611.1M in total assets, up 23.5% year over year.
- How much debt does Tarsus Pharmaceuticals, Inc. have?
- Tarsus Pharmaceuticals, Inc. carries $88.8M in total debt against $346.7M of shareholders' equity, a debt-to-equity ratio of 0.26.
- How much cash does Tarsus Pharmaceuticals, Inc. have?
- Tarsus Pharmaceuticals, Inc. holds $206.6M in cash and equivalents.
- Can Tarsus Pharmaceuticals, Inc. cover its short-term obligations?
- Its current ratio is 3.20 — current assets exceed current liabilities.
- Where does Tarsus Pharmaceuticals, Inc.'s balance sheet data come from?
- Every line is extracted from Tarsus Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
